4//SEC Filing
Viret Jean-Frederic 4
Accession 0001209191-23-057214
CIK 0001426332other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 4:27 PM ET
Size
5.5 KB
Accession
0001209191-23-057214
Insider Transaction Report
Form 4
Viret Jean-Frederic
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-12-01+450,000→ 450,000 totalExercise: $0.77Exp: 2033-11-30→ Common Stock (450,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest over a four-year period commencing November 3, 2023, with 1/4th of the shares vesting on November 3, 2024 and 1/48th of the shares vesting monthly thereafter.
Documents
Issuer
NGM BIOPHARMACEUTICALS INC
CIK 0001426332
Entity typeother
Related Parties
1- filerCIK 0001427569
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 4:27 PM ET
- Size
- 5.5 KB